Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Modifying Provider Vitamin D Screening Behavior in Primary Care.

Rozario NL, Sparling A, Burns R, McWilliams A, Brady JH, Kowalkowski M, Roberge J.

J Am Board Fam Med. 2020 Mar-Apr;33(2):252-261. doi: 10.3122/jabfm.2020.02.190323.

2.

Effect of a Virtual Patient Navigation Program on Behavioral Health Admissions in the Emergency Department: A Randomized Clinical Trial.

Roberge J, McWilliams A, Zhao J, Anderson WE, Hetherington T, Zazzaro C, Hardin E, Barrett A, Castro M, Balfour ME, Rachal J, Krull C, Sparks W.

JAMA Netw Open. 2020 Jan 3;3(1):e1919954. doi: 10.1001/jamanetworkopen.2019.19954.

3.

A Population Health Approach to Transitional Care Management for High-Risk Patients with Diabetes: Outcomes at a Rural Hospital.

Taylor YJ, Roberge J, Rossman W, Jones J, Generoso C, Bobay C, DeSilva B, Evans C, Pracht M, Dulin MF, Davis CJ.

Popul Health Manag. 2019 Nov 25. doi: 10.1089/pop.2019.0119. [Epub ahead of print]

PMID:
31765271
4.
5.

Chemisorption-repulsion energies of H2 on surface (110) of Mg1-xMx alloys (M = Al, Ni, Zn; 0.0 ≤ x ≤ 0.20) as a function of temperature.

Ramírez-Dámaso G, Ramírez-Rodríguez O, Caballero F, Castillo-Alvarado FL, Roberge J, Solorza-Guzmán M, Rojas-Hernández E, Ortiz-Ubilla A, Romo-Rico D.

J Mol Model. 2019 Oct 26;25(11):326. doi: 10.1007/s00894-019-4214-1.

PMID:
31655912
6.

A comparison of methodologies for the real-time identification of hospitalized patients with acute exacerbations of COPD.

Shah P, McWilliams A, Howard D, Roberge J.

Int J Chron Obstruct Pulmon Dis. 2019 Mar 22;14:693-698. doi: 10.2147/COPD.S175296. eCollection 2019.

7.

Optimising patient active role with a user-centred eHealth platform (CONCERTO+) in chronic diseases management: a study protocol for a pilot cluster randomised controlled trial.

Gagnon MP, Ndiaye MA, Larouche A, Chabot G, Chabot C, Buyl R, Fortin JP, Giguère A, Leblanc A, Légaré F, Motulsky A, Sicotte C, Witteman HO, Kavanagh E, Lépinay F, Roberge J, Délétroz C, Abbasgholizadeh-Rahimi S.

BMJ Open. 2019 Apr 2;9(4):e028554. doi: 10.1136/bmjopen-2018-028554.

8.

Combining Lean and Applied Research methods to improve rigor and efficiency in acute care outcomes research: A case study.

McWilliams A, Schoen M, Krull C, Bilancia J, Bacon M, Pena E, McCall A, Howard D, Roberge J.

Contemp Clin Trials Commun. 2019 Jan 9;14:100322. doi: 10.1016/j.conctc.2019.100322. eCollection 2019 Jun.

9.

Lifestyle Habits, Dietary Factors, and the Metabolically Unhealthy Obese Phenotype in Youth.

Roberge JB, Van Hulst A, Barnett TA, Drapeau V, Benedetti A, Tremblay A, Henderson M.

J Pediatr. 2019 Jan;204:46-52.e1. doi: 10.1016/j.jpeds.2018.08.063. Epub 2018 Oct 23.

PMID:
30366774
10.

Aiming to Improve Readmissions Through InteGrated Hospital Transitions (AIRTIGHT): a Pragmatic Randomized Controlled Trial.

McWilliams A, Roberge J, Anderson WE, Moore CG, Rossman W, Murphy S, McCall S, Brown R, Carpenter S, Rissmiller S, Furney S.

J Gen Intern Med. 2019 Jan;34(1):58-64. doi: 10.1007/s11606-018-4617-1. Epub 2018 Aug 14.

11.

Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells.

Del'Guidice T, Lepetit-Stoffaes JP, Bordeleau LJ, Roberge J, Théberge V, Lauvaux C, Barbeau X, Trottier J, Dave V, Roy DC, Gaillet B, Garnier A, Guay D.

PLoS One. 2018 Apr 4;13(4):e0195558. doi: 10.1371/journal.pone.0195558. eCollection 2018.

12.

Modified forest rotation lengths: Long-term effects on landscape-scale habitat availability for specialized species.

Roberge JM, Öhman K, Lämås T, Felton A, Ranius T, Lundmark T, Nordin A.

J Environ Manage. 2018 Mar 15;210:1-9. doi: 10.1016/j.jenvman.2017.12.022. Epub 2018 Jan 9.

PMID:
29329003
13.

Projecting biodiversity and wood production in future forest landscapes: 15 key modeling considerations.

Felton A, Ranius T, Roberge JM, Öhman K, Lämås T, Hynynen J, Juutinen A, Mönkkönen M, Nilsson U, Lundmark T, Nordin A.

J Environ Manage. 2017 Jul 15;197:404-414. doi: 10.1016/j.jenvman.2017.04.001. Epub 2017 Apr 12.

PMID:
28411568
14.

Varying rotation lengths in northern production forests: Implications for habitats provided by retention and production trees.

Felton A, Sonesson J, Nilsson U, Lämås T, Lundmark T, Nordin A, Ranius T, Roberge JM.

Ambio. 2017 Apr;46(3):324-334. doi: 10.1007/s13280-017-0909-7. Epub 2017 Feb 24.

15.

The Use of Vibrotactile Feedback to Restore Texture Recognition Capabilities, and the Effect of Subject Training.

Motamedi MR, Roberge JP, Duchaine V.

IEEE Trans Neural Syst Rehabil Eng. 2017 Aug;25(8):1230-1239. doi: 10.1109/TNSRE.2016.2621068. Epub 2016 Oct 25.

PMID:
28113772
16.

Cross-Talk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism.

Audet-Delage Y, Rouleau M, Rouleau M, Roberge J, Miard S, Picard F, Têtu B, Guillemette C.

Mol Pharmacol. 2017 Mar;91(3):167-177. doi: 10.1124/mol.116.106161. Epub 2017 Jan 3.

17.

Aiming to Improve Readmissions Through InteGrated Hospital Transitions (AIRTIGHT): study protocol for a randomized controlled trial.

McWilliams A, Roberge J, Moore CG, Ashby A, Rossman W, Murphy S, McCall S, Brown R, Carpenter S, Rissmiller S, Furney S.

Trials. 2016 Dec 19;17(1):603.

18.

'Life in the age of screens': parent perspectives on a 24-h no screen-time challenge.

Peláez S, Alexander S, Roberge JB, Henderson M, Bigras JL, Barnett TA.

Clin Obes. 2016 Aug;6(4):273-80. doi: 10.1111/cob.12150. Epub 2016 May 31.

PMID:
27242271
19.

Replacing monocultures with mixed-species stands: Ecosystem service implications of two production forest alternatives in Sweden.

Felton A, Nilsson U, Sonesson J, Felton AM, Roberge JM, Ranius T, Ahlström M, Bergh J, Björkman C, Boberg J, Drössler L, Fahlvik N, Gong P, Holmström E, Keskitalo EC, Klapwijk MJ, Laudon H, Lundmark T, Niklasson M, Nordin A, Pettersson M, Stenlid J, Sténs A, Wallertz K.

Ambio. 2016 Feb;45 Suppl 2:124-39. doi: 10.1007/s13280-015-0749-2.

20.

Socio-ecological implications of modifying rotation lengths in forestry.

Roberge JM, Laudon H, Björkman C, Ranius T, Sandström C, Felton A, Sténs A, Nordin A, Granström A, Widemo F, Bergh J, Sonesson J, Stenlid J, Lundmark T.

Ambio. 2016 Feb;45 Suppl 2:109-23. doi: 10.1007/s13280-015-0747-4.

21.

Relative contributions of set-asides and tree retention to the long-term availability of key forest biodiversity structures at the landscape scale.

Roberge JM, Lämås T, Lundmark T, Ranius T, Felton A, Nordin A.

J Environ Manage. 2015 May 1;154:284-92. doi: 10.1016/j.jenvman.2015.02.040. Epub 2015 Mar 5.

PMID:
25745845
22.

Relation of dietary inorganic arsenic to serum matrix metalloproteinase-9 (MMP-9) at different threshold concentrations of tap water arsenic.

Kurzius-Spencer M, Harris RB, Hartz V, Roberge J, Hsu CH, O'Rourke MK, Burgess JL.

J Expo Sci Environ Epidemiol. 2016 Sep;26(5):445-51. doi: 10.1038/jes.2014.92. Epub 2015 Jan 21.

23.

Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes.

Xu G, Lv B, Roberge JY, Xu B, Du J, Dong J, Chen Y, Peng K, Zhang L, Tang X, Feng Y, Xu M, Fu W, Zhang W, Zhu L, Deng Z, Sheng Z, Welihinda A, Sun X.

J Med Chem. 2014 Feb 27;57(4):1236-51. doi: 10.1021/jm401780b. Epub 2014 Feb 12.

PMID:
24456245
24.

Dual roles for splice variants of the glucuronidation pathway as regulators of cellular metabolism.

Rouleau M, Roberge J, Bellemare J, Guillemette C.

Mol Pharmacol. 2014 Jan;85(1):29-36. doi: 10.1124/mol.113.089227. Epub 2013 Oct 18.

25.

Contribution of diet to aggregate arsenic exposures-an analysis across populations.

Kurzius-Spencer M, Burgess JL, Harris RB, Hartz V, Roberge J, Huang S, Hsu CH, O'Rourke MK.

J Expo Sci Environ Epidemiol. 2014 Mar-Apr;24(2):156-62. doi: 10.1038/jes.2013.37. Epub 2013 Jul 17.

26.

Evidence-based knowledge versus negotiated indicators for assessment of ecological sustainability: the Swedish Forest Stewardship Council standard as a case study.

Angelstam P, Roberge JM, Axelsson R, Elbakidze M, Bergman KO, Dahlberg A, Degerman E, Eggers S, Esseen PA, Hjältén J, Johansson T, Müller J, Paltto H, Snäll T, Soloviy I, Törnblom J.

Ambio. 2013 Mar;42(2):229-40. doi: 10.1007/s13280-012-0377-z.

27.

Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.

Chao H, Turdi H, Herpin TF, Roberge JY, Liu Y, Schnur DM, Poss MA, Rehfuss R, Hua J, Wu Q, Price LA, Abell LM, Schumacher WA, Bostwick JS, Steinbacher TE, Stewart AB, Ogletree ML, Huang CS, Chang M, Cacace AM, Arcuri MJ, Celani D, Wexler RR, Lawrence RM.

J Med Chem. 2013 Feb 28;56(4):1704-14. doi: 10.1021/jm301708u. Epub 2013 Feb 18.

PMID:
23368907
28.

The relative protein abundance of UGT1A alternative splice variants as a key determinant of glucuronidation activity in vitro.

Rouleau M, Roberge J, Falardeau SA, Villeneuve L, Guillemette C.

Drug Metab Dispos. 2013 Apr;41(4):694-7. doi: 10.1124/dmd.112.050468. Epub 2013 Jan 29.

29.

Environmental arsenic exposure and serum matrix metalloproteinase-9.

Burgess JL, Kurzius-Spencer M, O'Rourke MK, Littau SR, Roberge J, Meza-Montenegro MM, Gutiérrez-Millán LE, Harris RB.

J Expo Sci Environ Epidemiol. 2013 Mar;23(2):163-9. doi: 10.1038/jes.2012.107. Epub 2012 Dec 12.

30.

Binational arsenic exposure survey: methodology and estimated arsenic intake from drinking water and urinary arsenic concentrations.

Roberge J, O'Rourke MK, Meza-Montenegro MM, Gutiérrez-Millán LE, Burgess JL, Harris RB.

Int J Environ Res Public Health. 2012 Apr;9(4):1051-67. doi: 10.3390/ijerph9041051. Epub 2012 Mar 26.

31.

Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants.

Ménard V, Eap O, Roberge J, Harvey M, Lévesque E, Guillemette C.

Pharmacogenet Genomics. 2011 Oct;21(10):631-41. doi: 10.1097/FPC.0b013e3283498147.

PMID:
21881541
32.

C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

Xu B, Feng Y, Cheng H, Song Y, Lv B, Wu Y, Wang C, Li S, Xu M, Du J, Peng K, Dong J, Zhang W, Zhang T, Zhu L, Ding H, Sheng Z, Welihinda A, Roberge JY, Seed B, Chen Y.

Bioorg Med Chem Lett. 2011 Aug 1;21(15):4465-70. doi: 10.1016/j.bmcl.2011.06.032. Epub 2011 Jun 16.

PMID:
21737266
33.

Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico.

Gomez-Rubio P, Roberge J, Arendell L, Harris RB, O'Rourke MK, Chen Z, Cantu-Soto E, Meza-Montenegro MM, Billheimer D, Lu Z, Klimecki WT.

Toxicol Appl Pharmacol. 2011 Apr 15;252(2):176-82. doi: 10.1016/j.taap.2011.02.007. Epub 2011 Feb 12.

34.

EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c) levels in db/db mice and prolongs the survival of stroke-prone rats.

Zhang W, Welihinda A, Mechanic J, Ding H, Zhu L, Lu Y, Deng Z, Sheng Z, Lv B, Chen Y, Roberge JY, Seed B, Wang YX.

Pharmacol Res. 2011 Apr;63(4):284-93. doi: 10.1016/j.phrs.2011.01.001. Epub 2011 Jan 5.

PMID:
21215314
35.

Design and synthesis of a G-protein-coupled receptor antagonist library of aryloxyalkanolamines using a polymer-supported acyclic acetal linker.

Roberge JY, Harikrishnan LS, Kamau MG, Ruan Z, Van Kirk K, Liu Y, Cooper CB, Poss MA, Dickson JK Jr, Gavai AV, Chao ST, Leith LW, Bednarz MS, Mathur A, Kakarla R, Schnur DM, Vaz R, Lawrence RM.

J Comb Chem. 2009 Jan-Feb;11(1):72-82. doi: 10.1021/cc800051u.

PMID:
19086798
36.

Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists.

Gavai AV, Vaz RJ, Mikkilineni AB, Roberge JY, Liu Y, Lawrence RM, Corte JR, Yang W, Bednarz M, Dickson JK Jr, Ma Z, Seethala R, Feyen JH.

Bioorg Med Chem Lett. 2005 Dec 15;15(24):5478-82. Epub 2005 Oct 10.

PMID:
16216508
37.

Discovery and structure-activity relationships of 2-benzylpyrrolidine-substituted aryloxypropanols as calcium-sensing receptor antagonists.

Yang W, Wang Y, Roberge JY, Ma Z, Liu Y, Michael Lawrence R, Rotella DP, Seethala R, Feyen JH, Dickson JK Jr.

Bioorg Med Chem Lett. 2005 Feb 15;15(4):1225-8.

PMID:
15686947
38.

Automated volumetric flow quantification using angle-corrected color Doppler image.

Kim B, Soble JS, Stamos TD, Neumann A, Robergé J.

Echocardiography. 2004 Jul;21(5):399-408.

PMID:
15209718
39.

Identification of purine inhibitors of phosphodiesterase 7 (PDE7).

Pitts WJ, Vaccaro W, Huynh T, Leftheris K, Roberge JY, Barbosa J, Guo J, Brown B, Watson A, Donaldson K, Starling GC, Kiener PA, Poss MA, Dodd JH, Barrish JC.

Bioorg Med Chem Lett. 2004 Jun 7;14(11):2955-8.

PMID:
15125967
40.

Characterization of a new class of selective nonsteroidal progesterone receptor agonists.

Dong Y, Roberge JY, Wang Z, Wang X, Tamasi J, Dell V, Golla R, Corte JR, Liu Y, Fang T, Anthony MN, Schnur DM, Agler ML, Dickson JK Jr, Lawrence RM, Prack MM, Seethala R, Feyen JH.

Steroids. 2004 Mar;69(3):201-17.

PMID:
15072922
41.

Two-dimensional gap analysis: a tool for efficient conservation planning and biodiversity policy implementation.

Angelstam P, Mikusiński G, Rönnbäck BI, Ostman A, Lazdinis M, Roberge JM, Arnberg W, Olsson J.

Ambio. 2003 Dec;32(8):527-34.

PMID:
15049349
42.

Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56(Lck).

Chen P, Norris D, Iwanowicz EJ, Spergel SH, Lin J, Gu HH, Shen Z, Wityak J, Lin TA, Pang S, De Fex HF, Pitt S, Shen DR, Doweyko AM, Bassolino DA, Roberge JY, Poss MA, Chen BC, Schieven GL, Barrish JC.

Bioorg Med Chem Lett. 2002 May 20;12(10):1361-4.

PMID:
11992777
43.

Effects of OspA vaccination on Lyme disease serologic testing.

Aguero-Rosenfeld ME, Roberge J, Carbonaro CA, Nowakowski J, Nadelman RB, Wormser GP.

J Clin Microbiol. 1999 Nov;37(11):3718-21.

44.
45.

A strategy for a convergent synthesis of N-linked glycopeptides on a solid support.

Roberge JY, Beebe X, Danishefsky SJ.

Science. 1995 Jul 14;269(5221):202-4.

PMID:
7618080
47.

Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients.

Roberge JN, Brubaker PL.

Endocrinology. 1991 Jun;128(6):3169-74.

PMID:
2036983
48.

Proglucagon-derived peptides in the neuroendocrine system.

Brubaker PL, Stobie KM, Roberge JN, Lui EY, Drucker DJ.

Adv Exp Med Biol. 1991;291:143-59. Review.

PMID:
1927680
49.

Human abductor pollicis brevis muscle "divisions" and the nerve hila.

Simard T, Roberge J.

Anat Rec. 1988 Dec;222(4):426-36.

PMID:
3228211
50.

Long-term results of low power, long duration laser trabeculoplasty.

Blondeau P, Roberge JF, Asselin Y.

Am J Ophthalmol. 1987 Oct 15;104(4):339-42.

PMID:
3661641

Supplemental Content

Loading ...
Support Center